CSPC Pharmaceutical Group (CHJTF) Income Statement
CSPC Pharmaceutical Group Income Statement
Last quarter (Q2 2026), CSPC Pharmaceutical Group's total revenue was $18.34B, an increase of 11.72% from the same quarter last year. In Q2, CSPC Pharmaceutical Group's net income was $6.01B. See CSPC Pharmaceutical Group’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 25.33B | $ 29.54B | $ 31.47B | $ 31.59B | $ 27.41B | |
| $ 16.62B | $ 20.67B | $ 22.19B | $ 22.73B | $ 20.79B | |
| $ 12.75B | $ 15.22B | $ 15.19B | $ 15.80B | $ 14.64B | |
| Depreciation and Amortization | $ 1.37B | $ 1.34B | $ 1.12B | $ 1.05B | $ 865.47M |
| $ 5.24B | $ 7.16B | $ 8.59B | $ 8.83B | $ 7.58B | |
| $ 3.87B | $ 5.45B | $ 7.01B | $ 6.93B | $ 6.14B | |
| $ 815.45M | $ 229.71M | $ 388.72M | $ 811.55M | $ 591.96M | |
| $ 4.68B | $ 5.68B | $ 7.39B | $ 7.74B | $ 6.73B | |
| $ 3.78B | $ 4.41B | $ 5.88B | $ 6.22B | $ 5.51B | |
| Per Share Metrics | |||||
| Basic EPS | $ 0.33 | $ 0.38 | $ 0.50 | $ 0.52 | $ 0.46 |
| Diluted EPS | $ 0.33 | $ 0.38 | $ 0.49 | $ 0.52 | $ 0.46 |
| Weighted Average Shares Outstanding | 11.42B | 11.74B | 11.87B | 11.92B | 11.95B |
| Weighted Average Shares Outstanding (Diluted) | 11.42B | 11.74B | 11.87B | 11.92B | 11.95B |
Currency in CNY
